arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

PHIBRO ANIMAL HEALTH CORP

PAHC
$34.26 ▼ -1.23 (-3.47%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
56 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
68
Health
Good
Bullish
auto_awesome

Analytical Summary

PHIBRO ANIMAL HEALTH CORP shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $1.4B
Dividend Yield 0.35%
Revenue Growth 10.3%
Op. Margin 11.6%
ROIC 3.4%
FCF / Share $0.40
Trailing P/E 58.1x
Price / Book 3.8x
FCF Yield 1.2%
Debt / Equity 1.71
info Valuation on last close. End-of-day price, Aug 7, 2026.

56-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$383.54M
↑ +10.3%
Net Income Profit after all expenses
$24.02M
↑ +15.1%
Operating Margin Operating profit as % of sales
11.6%
↓ -13.5% 53th
FCF / Share Free cash flow per share
$0.40
↓ -16.3%
Long-Term Debt Long-term obligations
$620.52M
↓ -0.6%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
49
Returns
83
Financial Health
67
Cash Quality
82

Dividend History

Dividend / share · sourced from SEC filings
$0.48 Latest / share
+0.0% YoY
-4.8% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 15 years · 56 quarters